Peptidylarginine deiminase 2, 3 and 4 have distinct specificities against cellular substrates: Novel insights into autoantigen selection in rheumatoid arthritis

Annals of the Rheumatic Diseases

Volumn 71, Issue 1, 2012, Pages 92-98

  Darrah, Erika ^a   Rosen, Antony ^a   Giles, Jon T ^b   Andrade, Felipe ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ARGININE; BETA ACTIN; GAMMA ACTIN; IONOMYCIN; PEPTODYLARGININE DEIMINASE 2; PEPTODYLARGININE DEIMINASE 3; PEPTODYLARGININE DEIMINASE 4; PROTEIN ARGININE DEIMINASE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SPECIFICITY; ENZYME SUBSTRATE; FEMALE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MALE; MASS SPECTROMETRY; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RHEUMATOID ARTHRITIS;

ACTINS; AGED; AMINO ACID SEQUENCE; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; AUTOANTIGENS; CELLS, CULTURED; CITRULLINE; FEMALE; HUMANS; HYDROLASES; ISOENZYMES; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEUTROPHIL ACTIVATION; NEUTROPHILS; PROTEIN STRUCTURE, TERTIARY; SUBSTRATE SPECIFICITY;

EID: 84860390022     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2011.151712     Document Type: Article

References (36)

1. Vossenaar ER, Zendman AJ, van Venrooij WJ, et al. PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease. Bioessays 2003;25:1106-18. (Pubitemid 37411770)
2. Wegner N, Lundberg K, Kinloch A, et al. Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis. Immunol Rev 2010;233:34-54.
3. Foulquier C, Sebbag M, Clavel C, et al. Peptidyl arginine deiminase type 2 (PAD-2) and PAD-4 but not PAD-1, PAD-3, and PAD-6 are expressed in rheumatoid arthritis synovium in close association with tissue inflammation. Arthritis Rheum 2007;56:3541-53. (Pubitemid 350100687)
4. Chang X, Yamada R, Suzuki A, et al. Localization of peptidylarginine deiminase 4 (PADI4) and citrullinated protein in synovial tissue of rheumatoid arthritis. Rheumatology (Oxford) 2005;44:40-50. (Pubitemid 40124330)
5. Kinloch A, Lundberg K, Wait R, et al. Synovial fluid is a site of citrullination of autoantigens in inflammatory arthritis. Arthritis Rheum 2008;58:2287-95.
6. Suzuki A, Yamada R, Chang X, et al. Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat Genet 2003;34:395-402. (Pubitemid 36935332)
7. Nakashima K, Hagiwara T, Yamada M. Nuclear localization of peptidylarginine deiminase V and histone deimination in granulocytes. J Biol Chem 2002; 277:49562- 8.
8. Mastronardi FG, Wood DD, Mei J, et al. Increased citrullination of histone H3 in multiple sclerosis brain and animal models of demyelination: a role for tumor necrosis factorinduced peptidylarginine deiminase 4 translocation. J Neurosci 2006; 26:11387- 96.
9. Harris ML, Darrah E, Lam GK, et al. Association of autoimmunity to peptidyl arginine deiminase type 4 with genotype and disease severity in rheumatoid arthritis. Arthritis Rheum 2008;58:1958-67. (Pubitemid 351988087)
10. Andrade F, Darrah E, Gucek M, et al. Autocitrullination of human peptidyl arginine deiminase type 4 regulates protein citrullination during cell activation. Arthritis Rheum 2010;62:1630-40.
11. Goëb V, Thomas-L'Otellier M, Daveau R, et al. Candidate autoantigens identified by mass spectrometry in early rheumatoid arthritis are chaperones and citrullinated glycolytic enzymes. Arthritis Res Ther 2009;11:R38.
12. Schellekens GA, de Jong BA, van den Hoogen FH, et al. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 1998;101:273-81. (Pubitemid 28058927)
13. Girbal-Neuhauser E, Durieux JJ, Arnaud M, et al. The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues. J Immunol 1999;162:585-94. (Pubitemid 29018970)
14. Vossenaar ER, Radstake TR, van der Heijden A, et al. Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages. Ann Rheum Dis 2004;63:373-81. (Pubitemid 38453302)
15. Vossenaar ER, Després N, Lapointe E, et al. Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin. Arthritis Res Ther 2004;6:R142-50.
16. Kinloch A, Tatzer V, Wait R, et al. Identification of citrullinated alpha-enolase as a candidate autoantigen in rheumatoid arthritis. Arthritis Res Ther 2005;7:R1421-9.
17. Matsuo K, Xiang Y, Nakamura H, et al. Identification of novel citrullinated autoantigens of synovium in rheumatoid arthritis using a proteomic approach. Arthritis Res Ther 2006;8:R175.
18. Suzuki A, Yamada R, Ohtake-Yamanaka M, et al. Anti-citrullinated collagen type I antibody is a target of autoimmunity in rheumatoid arthritis. Biochem Biophys Res Commun 2005;333:418-26. (Pubitemid 40848307)
19. Burkhardt H, Sehnert B, Bockermann R, et al. Humoral immune response to citrullinated collagen type II determinants in early rheumatoid arthritis. Eur J Immunol 2005;35:1643-52. (Pubitemid 40691444)
20. Okazaki Y, Suzuki A, Sawada T, et al. Identification of citrullinated eukaryotic translation initiation factor 4G1 as novel autoantigen in rheumatoid arthritis. Biochem Biophys Res Commun 2006;341:94-100. (Pubitemid 43117390)
21. Asaga H, Nakashima K, Senshu T, et al. Immunocytochemical localization of peptidylarginine deiminase in human eosinophils and neutrophils. J Leukoc Biol 2001;70:46-51. (Pubitemid 32613661)
22. Neeli I, Khan SN, Radic M. Histone deimination as a response to inflammatory stimuli in neutrophils. J Immunol 2008;180:1895-902.
23. Kabsch W, Vandekerckhove J. Structure and function of actin. Annu Rev Biophys Biomol Struct 1992;21:49-76.
24. Khaitlina SY. Functional specificity of actin isoforms. Int Rev Cytol 2001;202:35-98. (Pubitemid 32291047)
25. Nomura K. Specificity and mode of action of the muscle-type protein-arginine deiminase. Arch Biochem Biophys 1992;293:362-9.
26. Stensland ME, Pollmann S, Molberg Ø, et al. Primary sequence, together with other factors, influence peptide deimination by peptidylarginine deiminase-4. Biol Chem 2009;390:99-107.
27. Schutt CE, Myslik JC, Rozycki MD, et al. The structure of crystalline profilin-beta-actin. Nature 1993;365:810-16.
28. Snir O, Widhe M, von Spee C, et al. Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles. Ann Rheum Dis 2009;68:736-43.
29. Hermansson M, Artemenko K, Ossipova E, et al. MS analysis of rheumatoid arthritic synovial tissue identifies specific citrullination sites on fibrinogen. Proteomics Clin Appl 2010;4:511-18.
30. P érez M L, Gómara MJ, Ercilla G, et al. Antibodies to citrullinated human fibrinogen synthetic peptides in diagnosing rheumatoid arthritis. J Med Chem 2007;50:3573-84.
31. Lundberg K, Kinloch A, Fisher BA, et al. Antibodies to citrullinated alpha-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase. Arthritis Rheum 2008;58:3009-19.
32. T akizawa Y, Suzuki A, Sawada T, et al. C itrullinated fibrinogen detected as a soluble citrullinated autoantigen in rheumatoid arthritis synovial fluids. Ann Rheum Dis 2006;65:1013-20.
33. Nakayama-Hamada M, Suzuki A, Kubota K, et al. Comparison of enzymatic properties between hPADI2 and hPADI4. Biochem Biophys Res Commun 2005;327:192-200. (Pubitemid 40051370)
34. Arita K, Hashimoto H, Shimizu T, et al. Structural basis for Ca(2+)-induced activation of human PAD4. Nat Struct Mol Biol 2004;11:777-83. (Pubitemid 39014504)
35. Arita K, Shimizu T, Hashimoto H, et al. Structural basis for histone N-terminal recognition by human peptidylarginine deiminase 4. Proc Natl Acad Sci U S A 2006;103:5291-6.
36. Knuckley B, Causey CP, Jones JE, et al. Substrate specificity and kinetic studies of PADs 1, 3, and 4 identify potent and selective inhibitors of protein arginine deiminase 3. Biochemistry 2010;49:4852-63.